PubMed HealthSearch

PubMed · 808569

'Sufficient' absorption--a quantitative method to replace 'exhaustive' absorption.

Abstract

At present, the only guideline for removal of undesired reactivities from an antiserum is that no activity against the cross-reacting (undesired) antigens should remain after exhaustive absorption. Since this guideline sets no upper limit on the amount of undesired antigens required for an exhaustive absorption, waste of possibly precious material and of time in performing multiple sequential absorptions can result. To minimize the quantity of antigen and of experimental work required for an absorption, a quantitative approach is suggested: the antiserum is test-absorbed with various amounts of the undesired antigens, and antibody activity still present against these antigens is then tested. The results can be plotted as a curve by use of Reif's modification of the Von Krogh equation. Thus, the exact amount of undersired antigens sufficient to remove all detectable reactivity against these antigens can be determined. The procedure is termed 'sufficient' rather than 'exhaustive' absorption, to stress that only detectable amounts (rather than every last trace) of undesirable antibodies have been removed. The nomenclat re 'exhaustive absorption' gives no indication that any practical attempt to achieve it can hardly escape having the same limitations as 'sufficient absorption'; it is therefore suggested that the misleading non-quantitative nomenclature 'exhaustive absorption' be eliminated from immunological terminology. 'Sufficient absorption' has been applied to the absorption of undesired (blood group) antibodies from rabbit antisera to CEA.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

A E Reif, C M Robinson. 1975. 'Sufficient' absorption--a quantitative method to replace 'exhaustive' absorption.. https://doi.org/10.1016/0022-1759(75)90087-3

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Intraplatelet von Willebrand factor and ABO blood group.

Levels of plasma Von Willebrand Factor (vWF) are known to be influenced by ABO Blood Group but such an influence on platelet vWF is not known. Forty-three healthy donors had blood drawn for measurement of plasma and platelet vWF, both antigenic (vWF:Ag) and functional (RCo). Twenty-six were Group O and seventeen were Group A. Groups did not differ in age, platelet count, hemoglobin, white cell counts, platelet rich plasma counts nor length of in vitro storage of samples prior to assay. Plasma levels of vWF:Ag and RCo was lower in Group O as expected. Platelet RCo was lower in Group O and such a trend was present for vWF:Ag. This influence of ABO Groups on platelet vWF was modest compared to that on plasma vWF.

ABO Blood-Group System

Animal histo-blood group ABO genes.

Sequences homologous to the human histo-blood group ABO genes are present in the genomic DNA of various mammals. We have PCR-amplified, subcloned, and sequenced a portion of these genes from several species of primates and found high conservation of the nucleotide as well as the deduced amino acid sequences during evolution.

ABO Blood-Group System